THE ROLE of the immune system during oncogenesis by mouse mammary-tumour virus (MTV) is yet to be completely elucidated. Humoral (Blair et al., 1966; Hilgers et al., 1971; lhle et al., 1976) and cellular (Blair, 1976; Creemers & Bentvelzen, 1977; Sigel et al., 1976; Stutman, 1976; Tagliabue et al., 1978) immunity against MTV antigens is expressed by MTVinfected mice relatively early in their life. However, since it has been established that immunosuppressive treatments such as neonatal thymectomy (Martinez, 1964; Heppner et al., 1968) or injections with antilymphocyte sera (Lappe & Blair, 1970) reduce the incidence and delay the appearance of mammary tumours in MTV-bearing hosts, a possible enhancing role for the immune system on tumour growth has been suggested for MTV tumorigenesis (Prehn & Lappe, 1971) .
In an attempt to provide a better understanding of the interactions between immune responses and MTV infections, we evaluated several in vitro immune parameters (Tagliabue et al., 1980) of virgin C3H/HeN (C3H) female mice infected with MTV for comparison with genetically identical C3H/HeN (C3Hf) mice freed of MTV by foster-nursing. It was found that C3H mice 14-20 weeks of age have cellmediated immunity against MTV antigens, measured as lymphokine production. By contrast, this reactivity is never detectable in younger or older C3H mice or in Accepte(d 7 Alay 1981 C3Hf mice of any age. Concomitantly to the lymphokine production, increased macrophage cytotoxic reactions (Tagliabue et al., 1980) were found in 14-20-week-old C3H mice. In parallel to their MTV-related activation, macrophages from C3H mice were also able to exert suppressive activities of lymphoproliferative responses. It was therefore suggested that the induction of suppressor macrophages could serve as a possible mechanism by which MTV overcome the host immune system. Since evidence in support of the existence of suppressive mechanisms has so far been obtained only in in vitro systems, it was felt of interest to investigate the possible in vivo relevance of the age-related immune modulation by MTV. For this purpose, C3H and C3Hf female mice of different ages (obtained from the Mammalian Genetics and Animal Production Service, National Cancer Institute, Bethesda, Md, through the courtesy of Dr R. B. Herberman, LID, NCI, NIH) were first studied for their ability to respond to a heterologous antigen such as sheep red blood cells (SRBC). Four days after the i.p. injection of 108 SRBC, splenocytes from immunized mice were tested for their ability to produce antibodies, using the technique of Jerne & Nordin (1963) . As shown in the two representative experiments of Table I , C3H mice 14-20 weeks of age have a statistically significant depression in plaque-forming cells, when those for C3Hf mice injected with variable numbers of MAT-21 tumour cells (Table  III) . Thus these results indicate that C3H mice are more susceptible to the MAT-21 tumour growth than C3Hf mice. This agrees with our previous findings with another mammary carcinoma (Tagliabue et al., 1978 (Tagliabue et al., , 1979 and with the observation of 0th & Sabolovic (1977) indicating that mammary tumours are more easily transplantable in histocompatible recipients when these have been reared on MTVcontaining milk. Furthermore, the observation that the MSTs of 14-20-week-old C3H mice were significantly shorter than those of younger C3H mice (Table III) is of particular interest. In fact, the higher susceptibility to the MAT-21 tumour growth of 14-20-week-old C3H mice can be considered further evidence of the in vivo relevance of the immunodepression caused by the MTV infection. Even though mammary tumours have been shown to be weakly immunogenic in MTV-infected mice (Prehn & Lappe, 1971 ) a cell-mediated immune response can be detected against non-viral tumour antigens (Vaage, 1968; Stutman, 1976; Tagliabue et al., 1979) . Thus the nonspecific immunodepression we found in 14-20-week-old C3H mice could contribute to the elimination of the non-viral anti-tumour immunity of these mice. This hypothesis is further supported by our results with the 3-methylcholanthrene 1023 fibrosarcoma of C3H mice. This MTV-free tumour was previously shown to be immunogenic in C3Hf mice (Zbar et al., 1980) . Table IV shows that no difference could be detected between C3H and C3Hf mice of any age when transplanted with the 1023 fibrosarcoma.
We previously observed that cellmediated immunity against non-viral anti- gens is developed only when the tumour becomes as large as 0 5-1 g (Tagliabue et al., 1979) . This mass can only be reached several days after the mammary tumour becomes palpable. Thus the discrepancy between MLPs and MSTs, the former being shorter in 8-week-old C3H mice and the latter shorter in 14-20-week-old C3H mice (Tables II and III) , and the results with the 1023 fibrosarcoma, further suggest that the immune depression of the older C31H mice acts preferentially on those mechanisms regulating the tumour growth after the host has been able to develop the specific immune response against tumour antigens.
In conclusion, these results indicate that the MTV infection induces a significant in vivo immunodepression that can be relevant to the survival of mice bearing transplanted mammary tumours. Whether this effect of MTV on the immune system is also important for the development of virus-induced tumours which become "clinically" evident later in life, remains to be elucidated.
